This illustration by the Mulittea team highlights how Vitamin D3 boosts calcium absorption, while Vitamin K2 acts as the perfect navigator, safely transporting calcium into your bones instead of arteries.

The Calcium Paradox: Why D3 Alone Isn’t Enough

Key Takeaways

▪️Vitamin D3 increases calcium absorption, while vitamin K2 directs that calcium into bones instead of blood vessels

▪️Without adequate vitamin K2, supplemental calcium may accumulate in arteries (vascular calcification), increasing cardiovascular risk

▪️The “calcium paradox” describes the simultaneous occurrence of low bone density and vascular calcification

▪️MK-7 (menaquinone-7) is the most bioavailable form of vitamin K2 for cardiovascular protection

▪️Clinical trials demonstrate that vitamin K2 supplementation slows the progression of coronary artery calcification

▪️Approximately 41% of U.S. adults are deficient or insufficient in vitamin D, and dietary vitamin K2 deficiency is also widespread



 

You take calcium for your bones. You may have added vitamin D3 to help absorption. It seems straightforward.

But here is what many supplement users do not realize: boosting calcium intake without also addressing vitamin K2 status might inadvertently support the wrong tissues.

This is not a niche concern. The global calcium supplements market was valued at over $13 billion in 2024 and continues to grow. With that growth comes an urgent need for better education about how calcium behaves in the body.

Enter the calcium paradox.

This is not alarmism. It is a well-documented physiological phenomenon first identified in 1966. In this article, we will break down what the calcium paradox means for your health, why vitamins D3 and K2 work together to solve it, and what the latest clinical research actually shows.

 

What Is the Calcium Paradox?

The calcium paradox describes a seemingly contradictory biological reality: calcium can be simultaneously depleted from bones while accumulating in blood vessel walls.

Think of it this way. Your body contains roughly one to two kilograms of calcium, with more than 99% stored in bones and teeth. This calcium is constantly being remodeled—some is deposited, some is withdrawn—in a tightly regulated cycle. When that regulatory system breaks down, calcium begins to leave the bones but ends up depositing in soft tissues, particularly in the arteries.

This process has real clinical consequences. Osteoporosis (weak, brittle bones) and atherosclerosis (hardened, calcified arteries) often occur in the same individuals. The calcium paradox helps explain why.

Vitamin K2 deficiency may be a key driver of this paradox. When the body lacks adequate K2, calcium-regulating proteins remain inactive, allowing calcium to drift away from bones and settle where it does not belong.

 

How Vitamin D3 and Vitamin K2 Work Together

To understand why D3 and K2 are partners rather than substitutes, it helps to know what each does.

Vitamin D3 enhances calcium absorption from the gut and increases circulating calcium levels. Vitamin D3 also stimulates the production of two key proteins involved in calcium regulation: osteocalcin and matrix Gla-protein (MGP).

But there is a catch. The proteins that D3 helps produce are inactive until vitamin K2 activates them. This is where the synergy becomes critical.

Vitamin K2—particularly the menaquinone-7 (MK-7) form—activates two essential vitamin K-dependent proteins:

▪️Osteocalcin: This protein binds calcium to the bone mineral matrix. Only when vitamin K2 carboxylates (activates) osteocalcin can it actually “glue” calcium into bones.

▪️Matrix Gla-Protein (MGP): This protein is synthesized by vascular smooth muscle cells and acts as the body’s most potent inhibitor of vascular calcification. MGP actively prevents calcium crystals from forming in artery walls. But like osteocalcin, MGP requires vitamin K2 to become biologically active.

Without sufficient K2, the calcium that vitamin D3 helps absorb may end up in arteries rather than bones. One source describes this as the essential “direction” mechanism: “While vitamin D3 increases calcium absorption, concurrent vitamin K2 supplementation is claimed to help ensure that this calcium is directed to bones (good) rather than accumulating in blood vessels (bad)”.

 

A woman is taking Mulittea D3K2 supplement

 

What Does the Clinical Evidence Say?

The science behind vitamin K2’s role in preventing vascular calcification is substantial and growing.

The VitaK-CAC Trial

Perhaps the most significant recent evidence comes from the VitaK-CAC trial—a double-blind, randomized, placebo-controlled study examining whether MK-7 supplementation could slow coronary artery calcification (CAC) progression. This study broke new ground by demonstrating, for the first time, that a vitamin can slow CAC progression.

The trial found that two years of MK-7 supplementation significantly slowed the progression of coronary artery calcification in patients with mild to moderate coronary artery disease—regardless of blood pressure status. MK-7 works by carboxylyzing matrix Gla-protein, the protein that protects against vascular calcium deposition.

Earlier Research on Post-Menopausal Women

A three-year study published in 2015 similarly found that MK-7 supplementation improved arterial flexibility through reduced calcification in healthy post-menopausal women.

Calcium Supplementation and Cardiovascular Risk

The concern about unguided calcium supplementation is not theoretical. A 2025 meta-analysis of adverse events from clinical trials found that calcium supplementation is associated with a 10-20% increased risk of myocardial infarction. Dietary calcium intake, by contrast, does not appear to carry the same risk, suggesting that the acute calcium-elevating effect of supplements may contribute to increased cardiovascular risk.

MESA Study

In the Multi-Ethnic Study of Atherosclerosis (MESA) with 10-year follow-up, calcium supplement use was associated with a 22% increased risk for incident coronary artery calcification after accounting for total calcium intake.

 

Why Vitamin K2 Deficiency Is More Common Than You Think

Despite its importance, vitamin K2 deficiency appears to be widespread. Clinicians from the Cleveland Clinic Foundation have stated: “There is an alarmingly high prevalence of vitamin K deficiency and suboptimal recommended intake among the general population in the US”.

A review of the literature indicates deficiencies in the American diet for vitamin K across race, ethnicity, and gender. For vitamin D3, data from NHANES shows approximately 41% of U.S. adults are deficient or insufficient.

This means millions of Americans may be taking calcium supplements—many also taking vitamin D—without the K2 needed to direct that calcium appropriately.

 

How Much Vitamin K2 and D3 Do You Need?

General supplement guidance (always consult your healthcare provider):

▪️Vitamin D3: 1,000–4,000 IU daily is common, depending on baseline blood levels and sun exposure

▪️Vitamin K2 (MK-7): 100–200 mcg daily is the typical range used in clinical trials

▪️Combination products that pair D3 and K2 in a single formula ensure the right ratio and simplify adherence

Note: Specific recommendations vary by individual. Blood testing for vitamin D levels can help determine appropriate dosing.

 

Frequently Asked Questions

Q: Can you take vitamin D3 without K2?

Yes, you can. But if you are taking higher doses of vitamin D3 (above 2,000 IU daily) or calcium supplements, adding vitamin K2 is likely beneficial. Vitamin D3 increases calcium absorption; K2 helps direct that calcium to bones rather than allowing it to accumulate in arteries. Without sufficient K2, the theoretical risk of vascular calcium deposition increases.

Q: What are the signs of vitamin K2 deficiency?

Overt K2 deficiency is difficult to detect without testing, as symptoms are not immediately obvious. Over time, low K2 status may contribute to arterial stiffness (measurable via vascular calcification scores), reduced bone density, and increased risk of cardiovascular events. Functional markers such as dp-ucMGP (dephosphorylated uncarboxylated MGP) can indicate inadequate vitamin K activity.

Q: Is the calcium paradox proven or still theoretical?

The calcium paradox is a well-established physiological concept supported by extensive research. It was first described in the scientific literature in 1966, and subsequent studies have consistently demonstrated the relationship between lower bone calcium content and increased vascular calcium content under various pathological conditions. What remains an active area of research is the extent to which vitamin K2 supplementation can reverse or prevent this process in different populations.

Q: What foods contain vitamin K2?

Vitamin K2 is found primarily in fermented foods and animal products. The richest dietary sources include:

▪️Natto (fermented soybeans)—exceptionally high in MK-7

▪️Hard cheeses (Gouda, Edam, Jarlsberg)

▪️Egg yolks (especially from pasture-raised chickens)

▪️Butter from grass-fed cows

▪️Chicken liver and other organ meats

▪️Sauerkraut and other fermented vegetables

Most Western diets provide very little MK-7, which is why supplementation is often recommended.

Q: Are there any safety concerns with vitamin K2?

Vitamin K2 (MK-7) has an excellent safety profile and is generally well tolerated even at high doses. Clinical trials lasting up to three years have reported no significant adverse effects. However, individuals taking blood-thinning medications (warfarin/Coumadin or other vitamin K antagonists) should consult their healthcare provider before using vitamin K supplements, as vitamin K interferes with the mechanism of these drugs. Newer anticoagulants (such as apixaban, rivaroxaban, and dabigatran) are not vitamin K antagonists and generally do not carry the same interaction.

Q: Can I get enough vitamin K2 from diet alone?

The short answer is: for most people following a standard Western diet, probably not. Natto is the only significant dietary source of meaningful amounts of MK-7, and it is rarely consumed outside of Japan. Cheese, egg yolks, and butter contain much smaller amounts. This is why many experts suggest that supplementation may be necessary to achieve the levels used in clinical studies (typically 100–200 mcg daily).

Q: What is the best time of day to take D3 and K2?

Vitamins D3 and K2 are fat-soluble, meaning they are best absorbed when taken with a meal containing fat—lunch or dinner is ideal. Many people prefer taking them in the morning or early afternoon, as higher vitamin D levels later in the day may theoretically interfere with melatonin production, though evidence for this is mixed. Splitting doses is unnecessary; once-daily combined products are convenient and effective.

 

Mulittea supplement offers several D3+K2 formulations for you to choose from.

 

Making Informed Choices: What to Look For

When choosing a D3 and K2 supplement, consider the following:

▪️Form of K2: Look for MK-7 (menaquinone-7) rather than MK-4. MK-7 has a longer half-life (approximately 72 hours) and has been the form used in most major clinical trials on vascular calcification.

▪️D3 source: Vitamin D3 (cholecalciferol) is the same form produced by human skin in response to sunlight and is more effective at raising blood vitamin D levels than D2.

▪️Dosage ratio: A common combination is 125 mcg (5,000 IU) of D3 with 100 mcg of MK-7 per serving.

A Trusted Option for D3 and K2

If you prefer a combined supplement that delivers both vitamins in clinically relevant amounts, Mulittea‘s Vitamin D3 and K2 collection offers several formulations to choose from. The product lineup includes various dosages and formats—such as different D3 to K2 ratios, softgels, or liquid drops—allowing you to select the option that best fits your individual needs and health goals. Each product in the collection pairs vitamin D3 (which enhances calcium absorption) with vitamin K2 as MK‑7 (the longer‑acting form shown in clinical trials like VitaK‑CAC to support arterial health). As always, consult your healthcare provider to determine which dosage and form are right for you, especially if you take blood‑thinning medications or have existing health conditions.

 

Closing Thoughts

The calcium paradox is not a reason to fear calcium or stop taking vitamin D. It is, however, a compelling reason to think more completely about how these nutrients work together.

Bone health and cardiovascular health are not separate systems. They are connected through the same calcium metabolism pathways, regulated by the same vitamin K-dependent proteins. Supporting one without supporting the other may leave the job half-finished.

For individuals taking calcium or vitamin D3 supplements—particularly those over 50, those at risk for osteoporosis, or those with cardiovascular concerns—ensuring adequate vitamin K2 status deserves attention.

 

References

▪️Cui, A., Xiao, P., Ma, Y., Fan, Z., Zhou, Z., Liao, Y., & Yu, Y. (2022). Prevalence and trend of vitamin D deficiency among adults in the United States: Analysis of NHANES 2001–2018. Frontiers in Nutrition, 9, 965376. https://doi.org/10.3389/fnut.2022.965376

▪️Knapen, M. H. J., Braam, L. A. J. L. M., Drummen, N. E., Bekers, O., Hoeks, A. P. G., & Vermeer, C. (2015). Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial. Thrombosis and Haemostasis, 113(5), 1135–1144. https://doi.org/10.1160/TH14-08-0675

▪️Reid, I. R. (2025). Calcium supplementation: Efficacy and safety. Current Osteoporosis Reports, 23, 8. https://doi.org/10.1007/s11914-025-00904-7

▪️Rennenberg, R. J. M. W., van Varik, B. J., Schurgers, L. J., et al. (2015). Menaquinone-7 supplementation to reduce vascular calcification in patients with coronary artery disease: Rationale and study protocol (VitaK-CAC Trial). Nutrients, 7(11), 8905–8919. https://doi.org/10.3390/nu7115443

▪️Vossen, L. M., Schurgers, L. J., van Varik, B. J., Kietselaer, B. L. J. H., Vermeer, C., Meeder, J. G., Rahel, B. M., van Cauteren, Y. J. M., Hoffland, G. A., Rennenberg, R. J. M. W., Reesink, K. D., & de Leeuw, P. W. (2015). Menaquinone-7 supplementation to reduce vascular calcification in patients with coronary artery disease: Rationale and study protocol (VitaK-CAC Trial). Nutrients, 7(11), 8905–8919. https://www.mdpi.com/2072-6643/7/11/5443

▪️Mulrooney, A. (2025, August 12). Millions of Americans are vitamin D deficient – Who is most at risk? GrassrootsHealth. https://www.grassrootshealth.net/blog/millions-of-americans-are-vitamin-d-deficient-who-is-most-at-risk/

 

Disclaimer: This article is for informational purposes only and does not constitute medical advice. The information presented here is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new supplement regimen, especially if you have pre-existing health conditions or are taking medications, including blood thinners.

Back to blog